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Abstract 
 This study is a prospective study that aimed to evaluate cognitive function in newly diagnosed epileptic patients 
before and 3 months after taking an antiepileptic drug by doing Wechsler IQ for patients before and 3 months 
after treatment and for their parents . the study included 40 patients. Divided into 4 groups  (each containing 10 
patients ) and subjected to one of the following AEDs  for  3  months : 1. group A : receiving Carbamazepine 
(Tegretol)  in a dose of 10-20 mg/kg/day,2. group B receiving Na valproate (Depakine) in a dose of 20-40 
mg/kg/day,3. group C : receiving Lamotrigine (Lamictal)  in a dose of 3-5 mg/kg/day,4. group D : receiving 
Topiramate in a dose of 3-6 mg/kg/day.Taking into consideration other factors that may be of Significance in 
affecting cognitive functions as seizure frequency ,age at onset of seizures and EEG abnormality. The results of 
the study were as following:1-There are statistically significant differences between IQs before and after 
treatment in the 4 groups. 2-there is +ve correlation between IQs before and after ttt in all groups.3- there is -ve 
correlation between IQs after ttt and frequency of seizures in group (B).4- There is +ve correlation between IQs 
of parents and patients΄ IQs before ttt in all groups.5-there is +ve correlation between IQs after ttt and parents' 
IQs  in all group,From these results we can conclude that  heredity is the main factor responsible for most of the 
decline in cognitive functions seen in epileptic patients after  treatment with AEDs and other factors as   seizure 
frequency, age at onset of seizures and EEG  abnormalities may also  play  a role,  By comparing the four groups 
we found that the impairment in cognitive function is mainly related to the impairment in cognitive function 
already present in those patients before the start of treatment. which were correlated and inherited in all groups. 
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1. Introduction 
In the Around 50 % million people  have epilepsy word wide ;it is especially prevalent in childhood , 
adolescence. Neuropsychological impairment is an important co-morbidity of epilepsy, people with epilepsy can 
develop behavioral and emotional problems and have an increased risk of poor self-esteem, depression and 
suicide. ( Elger CE et al, 2004 ). A long and rich history of research has characterized relationships between 
cognitive status and a variety of clinical epilepsy factors, including etiology, age of onset, seizure type and 
severity, duration, antiepileptic medications, and other factors (Aldenkamp A, Arends J.   2004). Controlled 
studies of children and adolescents with chronic epilepsy, but with substantially fewer years of recurrent seizures 
than the typical chronic adult population, have demonstrated that these patients may exhibit significant 
neuropsychological impairment (Jones J ,  et al ,   2004) , suggesting the influence of an early adverse neuro-
developmental impact on  cognition. Psychiatric or behavioral as well as academic problems may antedate the 
diagnosis of epilepsy not only in children but also in adults with epilepsy (Hesdorffer  DC, et al ,  2006 ). 
Memory impairments have been found to be more prevalent in symptomatic and cryptogenic epilepsies, when 
compared to idiopathic epilepsy (Klein et al, 2000; Mazzini et al, 2003). Among epilepsy syndromes occurring in 
children, those associated with cognitive or behavioural impairment include a) tuberous sclerosis which is 
characterized by autism and seizures (Bergin et al, 2000), b) pediatric epilepsy syndromes associated with mental 
retardation such as Lennox–Gastaut syndrome, and c) pediatric epilepsy syndromes characterized by prominent 
behavioral manifestations, such as Landau–Kleffner syndrome, an epileptic encephalopathy of which aphasia is 
the distinguishing feature (Ribbler et al, 1990). In contrast, idiopathic generalized epilepsies are more rarely 
associated with obvious or severe intellectual impairment (Giovagnoli et al, 1999).   In general, generalized 
tonic–clonic seizures are associated with greater cognitive impairment than partial seizures, whereas the highest 
risk is observed with status epilepticus (Rausch et al, 1991). Absence seizures also seem to be associated with 
lower cognitive performance compared with convulsive seizures . Seizures in temporal lobe epilepsy can damage 
the brain, and therefore they can negatively affect memory. this is most impressively demonstrated by TLE 
patients who became global amnesic after a convulsive or non-convulsive status epilepticus (Dietl T. et al. 2004). 
Antiepileptic drugs produce global changes in the excitation levels in the central nervous system and often lead 
to cognitive and behavioral deficits. These deficits vary and must be considered independently in every patient. 
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A number of consistent risk factors have been established. Poly-pharmacy and high blood levels of an 
antiepileptic drug (AED) increase the risk of cognitive side effects. Different effects have been demonstrated for 
some AEDs, but comparative data are incomplete across all of them. Other factors such as patient age and 
type/frequency of seizures may also be important contributors to the patient's cognitive state. AEDs can have 
positive or negative effects on mood, providing another consideration in choosing the course of treatment. 
(Meador,et al , 2005 ). A variety of factors beyond AEDs can affect cognitive function in patients with epilepsy. 
As a group, epilepsy patients have been shown to perform more poorly than normal controls on a variety of 
cognitive measures, although some epilepsy patients have superior cognitive abilities , the etiology of seizures is 
one of the primary determinants of the extent of cognitive impairment. Earlier onset of seizures, for example, 
frequently leads to more severe cognitive impairments. Seizure type, frequency, severity, and duration and 
cerebral lesions acquired before or developed as a consequence of seizures also contribute to cognitive function 
in epilepsy patients. (Carpay JA, et al, 2005) 
            The effects of AEDs on cognition are especially significant since AEDs are often be selected based on 
both traditional measures of treatment effectiveness such as efficacy and tolerability, and their negative 
neuropsychological side effects. The presence of AED-induced cognitive side effects is an important concern of 
epilepsy patients taking medications (Carpay JA, et al, 2005 ).Magnitude of AED-related cognitive dysfunction 
is generally modest in mono-therapy and when the AED is present at therapeutic  serum concentrations. 
However, there are circumstances in which decreased cognitive function assumes greater importance, such as 
learning in school children, when driving or operating machinery, and when cognitive skills might be especially 
vulnerable, such as in the elderly ( Bourgeois BF, 2004  ). 
 
 PATIENTS AND METHODS 
This study is carried out on forty , newly diagnosed, epileptic patients with their ages ranging between 7and 18 
years old who are divided into 4 groups A,B,C and D (each containing10 patients).      Each subjected to one of 
the following antiepileptic drugs for 3 months, Group(A) : receiving Carbamazepine (Tegretol)   at dose of 10-20 
mg/kg, Group(B): receiving Na valproate (Depakine) at dose of 20-40 mg/kg,Group (C): receiving Lamotrigine 
(Lamictal)  at dose of  3-5 mg/kg, Group (D): receiving Topiramate (Topiramate) at dose of 3-6mg/kg. All 
patients evaluated for cognitive functions by Wechsler IQ before and three months after treatment and also by 
subjecting their parents for Wechsler IQ taking into consideration other parameters that may be of significance in 
this study as seizures frequency, age at onset of epilepsy and EEG abnormality . Data are collected and 
statistically analyzed using,Mann Whitney test for correlation Statistic, Paired sample Statistic test   for 
evaluation of Statistic differences. 
 
Results 
Job-shop By comparing the IQ of all the studied patients before and after treatment , it was ranged from 
80-105 before treatment with a mean 91.65± 7.1 while it was ranged from 75 to 100 after treatment with a 
mean 88.75± 7.7 with significant difference(P<0.01)(Table 1).Among them, patients whose IQs were  < 90 
before treatment  , their mean IQs before treatment were 83.62 ± 3.12 while their mean IQs after treatment 
were 79.31 ± 3.57, there is a significant (+ve) correlation between IQs before and after ttt  in those patients 
whose IQs before treatment were < 90 (p- value<0.01 ),While those patients whose IQs before treatment 
were ≥ 90  , their mean IQs before treatment were 95.52 ± 4.73 with a mean IQs after treatment 93.3 ± 4.16 
with no significant difference . 
 
 Table 1: Comparison between IQ before and after treatment 
 Before treatment  After treatment  
Mean ± SD 91.65 ± 7.06 88.75 ± 7.72 
Range  80 – 105 75 – 100 
P-value 0.000* 
Paired samples t-test      * Statistical significant difference (P< 0.05) 
 
-Regarding the individual groups ,there was a significant difference  in each group between IQs before 
and after treatment. with no significant difference between the groups in the IQ values after treatment(Table 
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Table 2 : Before and after treatment IQs in different groups of the study. 








IQ before 92.5+85 91.3+5.8 91+7 91.8+7.6 
IQ after 89.1+8.3 89.1+7.4 87.7+7.6 89.1+5.6 
P-Value <0.001 <0.01 <0.01 <0.01 
significance significant significant Significant significant 
-There is statistically significant (+ve) correlation between IQs after treatment  and mothers' IQs and so 
like between patient after treatment and Father`s IQs in the all studied groups(p- value<0.05  )(Table 3&4). 
 
Table 3: Correlation between IQs of  Patients after treatment and mothers'  IQs 








IQ of mothers 90.5+7.1 90+6.4 92+7.7 92.1+7.2 
IQ after 89.1+8.3 89.1+7.4 87.7+7.6 89.1+5.6 
P-Value <0.05 <0.05 <0.002 <0.001 
significance significant significant Significant significant 
Table 4 : Correlation between IQs of  Patients after treatment and fathers'  IQs  








IQ of Fathers 92.5+2.5 93.5+8.6 89.8+6.7 92.5+8.5 
IQ after 89.1+8.3 89.1+7.4 87.7+7.6 89.1+5.6 
P-Value <0.05 <0.05 <0.01 <0.001 
significance significant significant Significant significant 
 
-From the study we conclude that there is a statistically highly significant difference between IQs before 
and after treatment in patients whose EEG are irritative (p value = 0.000 ) which is more significant than that 
of those patients whose EEGs are normal (p value = 0.029)(Tab 5). 
Table(5): IQ before and after treatment with the finding of the EEG. 
 Patients whose 
EEGs are irritative 
Patients whose 
EEGs are normal P-value 
Before treatment  Mean ± SD 91.2 ± 7.8 92.7 ± 5.1 
0.215 
Range  80 – 105 85 – 105 
After treatment  Mean ± SD 87.8 ± 8.4 91.1 ± 5.4 
0.558 
Range  75 – 100 80 – 100 
P-value 0.000* 0.029*  
Paired samples t-test      * Statistical significant difference (P < 0.05) 
-From the study we can conclude that there is statistically    non significant  (-ve) correlation between 
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Fig. (1): Correlation between patients' IQs after treatment and frequency of 
seizures  
 
-Regarding group A ,whose EEGs were normal (20% ) showed no difference in their mean IQs before 
and after treatment, while those whose EEGs were irritative (80% ) showed difference in their mean IQs 
before and after treatment, also there is a statistically significant difference between  IQs before and after 
treatment   in those whose IQs before treatment were < 90 (p-value 0.02). Indicating that those  patients 
whose IQs before treatment are lower , their parents' IQs tend to be low and their IQs are more liable to be 
affected after treatment. and vice versa  i.e those  patients whose IQs before treatment are higher , their 
parents' IQs tend to be high and their IQs are less liable to be affected after treatment. and this conclusion 
may support the role of heredity in cognitive affection after treatment with AEDs. 
-Regarding group B, whose EEGs were normal (30% ) showed mild difference in their mean IQs before 
and after treatment, while those whose EEGs were irritative (70% ) showed marked difference in their mean 
IQs before and after treatment. Also there is a statistically highly significant (-ve) correlation between IQs 
after treatment and Seizure Frequency (p-value<0.01). Furthermore, we can find out that in those patients 
whose IQs before treatment were < 90 show  statistically significant difference between their IQs before and 
after treatment, while whose IQs before treatment were ≥ 90, show  statistically no significant difference 
between their IQs before and after treatment. 
-Regarding group C, whose EEGs were normal (40% ) showed some difference in their mean IQs before 
and after treatment, while those whose EEGs are irritative (60% ) showed larger difference in their mean IQs 
before and after treatment. However, in group D there is statistically significant (+ve) correlation between 





In our study we found that there is +ve correlation between  the age at onset of seizures and   
the     impairment  in cognitive functions in epileptics   i.e. the younger the patient at the onset of 
seizure, the lesser the decline in cognitive function, in partial disagreement with several studies done 
of  Dodrill  CB,  et al, 1992 with Liu,et al, 2002    which  emphasized that age of onset is, in fact, the 
most  important  predictor  of cognitive   outcome in patients with epilepsy. Regard the effect of 
seizure frequency on  cognitive   functions in epileptic patients, the present study revealed that there 
is  (-ve) correlation between  seizure frequency and cognitive outcome in all patients and in group (B 
) i.e. the higher the frequency of seizure , the lower the cognitive outcome . this  result  come in 
agreement  with  study  of Tonekaboni, et al, 2006. however , and in disagreement with   study done 
by  Glória Maria , et al, 1999  who found that no relationship was found between the number of the 
attacks of benign Rolandic epilepsy with centro-temporal spikes (CTS ) and the results in the WISC-
III (Wechsler Intelligence Scale for Children—3rd copy ).  
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  In the present study, There is statistically highly significant difference between IQs before and after 
treatment in patients whose EEG are irritative ,which is more significant than that of those patients whose EEGs 
are normal ,this discrepancy between the two subgroups which may apparently attributed to EEG abnormalities , 
may be actually attributed to other factors as higher frequency of seizures . This results are in  partial 
disagreement with   study done by  Pinton  F. , et al , 2006  who found that  no significant association was 
observed in their study between inferior performance in the WISC  and the EEG abnormality. In the present 
study there is (+ve) correlation between IQ before and after treatment in the 4 groups  i.e. IQ after ttt is in direct 
proportional to IQ before treatment, In other words, patients with lower IQ before treatment are   more  liable  to 
decline of their IQs after treatment with the AEDs and this reflect the effect of the hereditary factor  as a major 
counterpart that affect cognitive function . IQs of patients after treatment is in statistically significant ( +ve) 
correlation with that of their parents. and with  patient's IQs before   treatment Which in turn may reflect , to a 
great extent, the role of heredity as an important  factor  in cognitive change after usage of AEDs. This 
conclusion comes in agreement with   Deckers, et al, 2000. 
     The difference in  cognitive functions seen in group A and  B which may be attributed ,in partial to ,CBZ and 
VPA respectively  comes in agreement with Dodrill , 2000 who in their study  found that both  CBZ and VPA 
have similar cognitive effects which are typically mild in magnitude. And in partial  disagreement with Cavanna 
2010 who mentioned that, the active metabolite CBZ-epoxide is partly responsible for the mild cognitive and 
psychomotor effects attributed to CBZ. Also in partial  disagreement with Lee et al., 2006 and Mula,et al ,2006 
who also mentioned that CBZ may cause irritability, impaired attention and behavioral problems in patients with 
existing behavioral difficulties. 
 The difference in  cognitive functions seen in group  C and  D which may be attributed ,in partial to 
,LTG and TPM  respectively . It comes  in agreement with Meador, et al , 2005 who found that in two 
large studies LTG has fewer central effects than CBZ  or PHT ,also in agreement with  Pavel , et al , 
2004 who found that topiramate had more deleterious effect on cognition than LTG and VPA in study 
don on volunteers. in partial disagreement with Jokeit and  Ebner, 2002 who found that LTG has a 
favorable cognitive and behavioral profile in epilepsy patients and in partial disagreement with Mula 
et al., 2006 Who added LTG diminishes depression and mania and has mood stabilizing effect as well 
as improves energy and social function . As regard group D the result of our study come in agreement 
with the study of Martin, et al ; 1999  who found, in a study on volunteers, that TPM  produce 
significantly greater effect on cognitive function than LTG and GBP. and in disagreement with 
Loring, 2007 who found in a comparative study between TPM and VPA when added to CBZ. And 
after analysis of individual data .that scores were generally unchanged or even improved after TPM 
and VPA. This means that there is a subset of Patients Who are particularly susceptible to the 
cognitive side effects of TPM.  in  disagreement with  Sloviter et al., 2003 who mentioned that 
Cognitive and behavioral problems associated with TPM use are of significant concern in patients 
with epilepsy and in disagreement with Caplan, et al, 2008 who mentioned that both cognitive and 
behavioral problems with TPM are less frequent and severe when the starting dose is low and 
increased slowly. Our study demonstrated that , the main factor responsible for the cognitive decline 
with the use of the AEDs is the heredity , come in agreement with Desai, 2008  who mentioned that 
heredity had a major role in cognitive affection in addition to other factors as epilepsy itself ,  
medications and brain injuries already present. and In partial  agreement with Blake ,et al, 2000 who 
mentioned that AEDs can positively improve mood and behaviour through anti-seizures mechanisms 
or release phenomenon (i.e. successful seizure control with AED is associated with a positive impact 
on alertness and cognition) and in partial agreement with  Seo, et al, 2007 who mentioned that it is 
currently not possible to predict which patient with epilepsy will tolerate an AED or develop positive 
or negative psychotropic effects. As regard the -ve effect of  seizure frequency on cognitive functions, 
that our study demonstrated that seizure frequency had –ve effect on cognitive functions and this 
result come in  agreement with Aldenkamp and Arends 2005 who concluded that within a population 
of patients with all kinds of seizures, those with more than 100 secondary generalized seizures 
perform less well on tests for intellectual and cognitive functioning, including memory as well as 
long-time accumulation of intellectual deterioration due to multiple seizures. As regard the EEG , our 
study revealed that EEG abnormality had –ve effect on cognition which come in agreement with  
Meador, 2002,who mentioned that the localization of the epileptic focus is also an important 
determinant of the extent and nature of cognitive deficits and in  partial agreement with Bergin et al, 
2000. Patients with TLE are reported to have more memory impairments than patients with extra-
temporal epilepsies and both groups have more memory impairments than patients with generalized 
epilepsies and in  agreement with Helmstaedter et al, 2001 who mentioned that Frontal lobe epilepsy 
is often associated with performance deficits in executive functioning In addition, foci in the left 
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temporal lobe are related to verbal memory impairments. Also, in  agreement with Kaufman et al, 
1997 and Blake et al, 2000.  
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